Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alternative Splicing | 16 | 2023 | 310 | 3.530 |
Why?
|
| Myotonic Dystrophy | 8 | 2023 | 74 | 2.530 |
Why?
|
| RNA-Binding Proteins | 13 | 2018 | 538 | 2.020 |
Why?
|
| Muscle, Skeletal | 8 | 2023 | 1004 | 1.350 |
Why?
|
| RNA, Messenger | 11 | 2019 | 2552 | 1.180 |
Why?
|
| CELF1 Protein | 6 | 2018 | 34 | 0.960 |
Why?
|
| RNA | 4 | 2017 | 515 | 0.860 |
Why?
|
| CRISPR-Cas Systems | 2 | 2017 | 315 | 0.840 |
Why?
|
| MEF2 Transcription Factors | 2 | 2014 | 34 | 0.840 |
Why?
|
| Heart | 4 | 2016 | 660 | 0.760 |
Why?
|
| Muscle Proteins | 4 | 2023 | 400 | 0.740 |
Why?
|
| Exons | 6 | 2019 | 760 | 0.710 |
Why?
|
| RNA Splicing Factors | 3 | 2018 | 51 | 0.690 |
Why?
|
| Myotonin-Protein Kinase | 2 | 2018 | 26 | 0.640 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 2333 | 0.620 |
Why?
|
| Calpain | 1 | 2018 | 43 | 0.550 |
Why?
|
| Proteostasis | 1 | 2018 | 36 | 0.540 |
Why?
|
| Muscle Weakness | 1 | 2018 | 90 | 0.540 |
Why?
|
| Calcium | 3 | 2017 | 1021 | 0.530 |
Why?
|
| Myoblasts | 2 | 2015 | 33 | 0.530 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 39 | 0.520 |
Why?
|
| Calcineurin | 1 | 2017 | 60 | 0.520 |
Why?
|
| DNA Repeat Expansion | 1 | 2017 | 38 | 0.510 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 102 | 0.480 |
Why?
|
| Growth and Development | 1 | 2016 | 20 | 0.480 |
Why?
|
| Fragile X Syndrome | 1 | 2016 | 148 | 0.440 |
Why?
|
| RNA Splicing | 4 | 2023 | 237 | 0.430 |
Why?
|
| Protein Isoforms | 5 | 2023 | 423 | 0.430 |
Why?
|
| Ataxia | 1 | 2016 | 157 | 0.430 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2018 | 83 | 0.420 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 217 | 0.420 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 48 | 0.410 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 174 | 0.410 |
Why?
|
| Muscle Development | 1 | 2014 | 73 | 0.410 |
Why?
|
| Muscular Diseases | 1 | 2015 | 124 | 0.400 |
Why?
|
| Animals | 18 | 2023 | 33856 | 0.400 |
Why?
|
| Mice | 13 | 2023 | 18219 | 0.390 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 138 | 0.390 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 468 | 0.380 |
Why?
|
| Myocardium | 2 | 2016 | 858 | 0.370 |
Why?
|
| Heart Diseases | 1 | 2016 | 500 | 0.350 |
Why?
|
| Mice, Knockout | 5 | 2023 | 3824 | 0.340 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 376 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 963 | 0.320 |
Why?
|
| Fibroblasts | 1 | 2014 | 852 | 0.310 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2009 | 7 | 0.300 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 109 | 0.290 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 670 | 0.280 |
Why?
|
| RNA Splice Sites | 2 | 2019 | 91 | 0.260 |
Why?
|
| Cell Nucleus | 3 | 2016 | 565 | 0.260 |
Why?
|
| MicroRNAs | 1 | 2014 | 888 | 0.250 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 1946 | 0.250 |
Why?
|
| Methylphenidate | 1 | 2006 | 58 | 0.240 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 131 | 0.230 |
Why?
|
| Molecular Biology | 1 | 2005 | 66 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 4 | 2015 | 410 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2005 | 269 | 0.200 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 246 | 0.200 |
Why?
|
| Animals, Newborn | 2 | 2017 | 1018 | 0.200 |
Why?
|
| Mutation | 1 | 2017 | 6093 | 0.200 |
Why?
|
| Heart Failure | 1 | 2016 | 2325 | 0.200 |
Why?
|
| LIM Domain Proteins | 1 | 2023 | 65 | 0.190 |
Why?
|
| Trans-Activators | 1 | 2005 | 700 | 0.180 |
Why?
|
| COS Cells | 3 | 2014 | 254 | 0.180 |
Why?
|
| Transcriptome | 3 | 2018 | 1111 | 0.180 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 155 | 0.180 |
Why?
|
| Hyaluronan Receptors | 1 | 2001 | 64 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2005 | 763 | 0.170 |
Why?
|
| Base Sequence | 4 | 2018 | 2734 | 0.150 |
Why?
|
| CD58 Antigens | 1 | 2019 | 7 | 0.150 |
Why?
|
| Alu Elements | 1 | 2019 | 66 | 0.140 |
Why?
|
| Humans | 18 | 2019 | 130506 | 0.140 |
Why?
|
| Physical Endurance | 1 | 2018 | 43 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2018 | 82 | 0.130 |
Why?
|
| Alleles | 2 | 2017 | 1675 | 0.130 |
Why?
|
| Horses | 1 | 2017 | 93 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 307 | 0.130 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 204 | 0.130 |
Why?
|
| Morpholinos | 1 | 2016 | 9 | 0.130 |
Why?
|
| Ion Transport | 1 | 2016 | 48 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 52 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 96 | 0.120 |
Why?
|
| Gene Targeting | 1 | 2017 | 171 | 0.120 |
Why?
|
| RNA Stability | 1 | 2016 | 75 | 0.120 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2016 | 20 | 0.120 |
Why?
|
| Cell Line | 2 | 2014 | 2558 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 237 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 278 | 0.120 |
Why?
|
| Introns | 3 | 2019 | 279 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2016 | 87 | 0.110 |
Why?
|
| Protein Transport | 1 | 2016 | 367 | 0.110 |
Why?
|
| Genes, myc | 1 | 2015 | 96 | 0.110 |
Why?
|
| CELF Proteins | 1 | 2015 | 7 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2018 | 767 | 0.110 |
Why?
|
| Spliceosomes | 1 | 2015 | 47 | 0.110 |
Why?
|
| Glucose | 2 | 2018 | 851 | 0.110 |
Why?
|
| Autophagy | 1 | 2018 | 422 | 0.110 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2015 | 37 | 0.110 |
Why?
|
| Tremor | 1 | 2016 | 126 | 0.110 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2016 | 241 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2016 | 594 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2014 | 277 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2014 | 396 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2018 | 801 | 0.100 |
Why?
|
| RNA Precursors | 3 | 2015 | 42 | 0.100 |
Why?
|
| Male | 7 | 2018 | 64503 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2015 | 691 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2014 | 805 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2001 | 2420 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1383 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1806 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 2008 | 0.080 |
Why?
|
| Brain | 2 | 2016 | 3170 | 0.080 |
Why?
|
| Base Pairing | 1 | 2009 | 40 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 1081 | 0.070 |
Why?
|
| Aging | 1 | 2016 | 1245 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2009 | 56 | 0.070 |
Why?
|
| Female | 7 | 2018 | 70401 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 177 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4713 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 1218 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2014 | 3355 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4669 | 0.070 |
Why?
|
| Trinucleotide Repeats | 1 | 2007 | 83 | 0.070 |
Why?
|
| Transfection | 2 | 2007 | 960 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 227 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 320 | 0.060 |
Why?
|
| Gene Amplification | 1 | 2005 | 220 | 0.060 |
Why?
|
| Genes | 1 | 2005 | 308 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2015 | 450 | 0.060 |
Why?
|
| tau Proteins | 1 | 2007 | 257 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 63 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2018 | 1000 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2001 | 425 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 831 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2602 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2006 | 1620 | 0.050 |
Why?
|
| Protein Binding | 3 | 2001 | 1656 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2333 | 0.040 |
Why?
|
| Purines | 1 | 2001 | 115 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 2397 | 0.040 |
Why?
|
| Neoplasms | 1 | 2014 | 2979 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 3470 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2004 | 687 | 0.040 |
Why?
|
| Clathrin Heavy Chains | 1 | 2018 | 2 | 0.040 |
Why?
|
| Clathrin Light Chains | 1 | 2018 | 3 | 0.040 |
Why?
|
| Binding Sites | 1 | 2001 | 1136 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 49 | 0.040 |
Why?
|
| Middle Aged | 3 | 2014 | 28401 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 535 | 0.030 |
Why?
|
| Adult | 3 | 2014 | 31142 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 665 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 9 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 56 | 0.030 |
Why?
|
| Cleavage Stimulation Factor | 1 | 2014 | 2 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2014 | 47 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 186 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 699 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 834 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 649 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2007 | 780 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 713 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 588 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1000 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1542 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 12853 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2006 | 14977 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3716 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 365 | 0.020 |
Why?
|
| RNA Probes | 1 | 2004 | 26 | 0.010 |
Why?
|
| Fetus | 1 | 2007 | 567 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 742 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1207 | 0.010 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 1999 | 8 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1999 | 148 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 1999 | 159 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1046 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 20887 | 0.000 |
Why?
|